Administrative CoreThis core will be directed by Dr. Wilson with Drs. Batshaw and Caplan serving as co-directors. The core willprovide basic administrative support to manage the financial operations of the program project to includeoversight of accounts, purchasing, and preparation and submission of reports to the institution, as well as tothe NIH. An External Scientific Advisory Committee (ESAC) will be convened, which will include scientistsknowledgeable about areas relevant to the grant including immunology, urea cycle disorders, AAV andvector safety assessment. An Ethics Advisory Board (EAB) will also be convened and chaired by Dr.Caplan. This Board will include a scientist from the ESAC, as well as parents of children with inheriteddiseases and people with expertise in ethics, policy, and law. The ESAC and EAB will convene on anannual basis to review the progress of the science and help the team address important issues related to theultimate clinical applications of gene therapy. Issues that will be considered by the EAB include target cellpopulations for early clinical trials, informed consent, inclusion and exclusion criteria, subject recruitment andcommunication with the community. The Core will also provide support .in biostatistics from Dr. RobertMcCarter. Dr. Joy Cavagnaro will serve as a consultant regarding FDA-related issues.Lay description. This Core will provide all administrative support for the implementation of the program. Bothan External Scientific Advisory Committee and an Ethics Advisory Board will be convened.
Showing the most recent 10 out of 26 publications
